Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Market

Request Customization

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Market Research Report - Size, Share, Growth, and Trend Analysis | Forecast (2025 - 2030)

Published: 2025 - Mar

Report Code: VMR-18241

Region: Global

Historic Range: 2022-2024

Forecast: 2025-2031

Format: Excel and PDF

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Market (2025-2030)

The Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Market encompasses the diagnosis, treatment, and management of a rare, heterogeneous group of tumors originating in the neuroendocrine cells of the gastrointestinal tract and pancreas. These tumors are classified into functional and non-functional types based on their hormonal activity, with therapeutic approaches spanning targeted therapies, somatostatin analogs, and radiopharmaceuticals.

Disruptive Impact and Opportunities:

GEP-NETs represent a rapidly evolving segment due to advancements in molecular diagnostics and precision therapies. Breakthrough treatments like radioligand therapies offer new approaches, redefining patient outcomes. Emerging administration methods and combination therapies provide easy integration into existing clinical pathways. Novel therapies demonstrate enhanced safety profiles (safe) compared to traditional cytotoxic agents. Expanding prevalence and unmet clinical needs in advanced stages create a big opportunity for stakeholders.

Emerging Drugs:

177Lu-edotreotide
CAM2029

Marketed Drugs:

Capecitabine (Xeloda)
5-fluorouracil (5-FU)
Doxorubicin (Adriamycin)

Key Companies:

Novartis
Ipsen Biopharmaceuticals
Pfizer
ITM Isotopen Technologien Muenchen
Camurus AB
Hutchison Medipharma Limited
Bristol-Myers Squibb
Eisai Limited
Experior S.L.
Tarveda Therapeutics
Roche Pharma

Market Segmentation:

By Type

Functional GEP-NETs
- Insulinomas
- Gastrinomas
- Glucagonomas
- Somatostatinomas
- VIPomas (Vasoactive Intestinal Peptide Tumors)
Non-Functional GEP-NETs

By Administration Type

Injectable
- Intravenous (IV)
- Subcutaneous (SC)
Oral

What’s in It for You?

Strategic Insights: Identify key trends, emerging therapies, and market disruptions.
Competitive Edge: Benchmark against industry leaders and emerging players.
Investment Opportunities: Explore high-growth segments and innovative therapies.
Market Entry Support: Gain actionable insights for effective go-to-market strategies.
Comprehensive Outlook: Understand the evolving landscape to make data-driven decisions.

📥 Download Sample Report

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

4250

Multi User

5250

Corporate User

6900

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe